Tech Company Financing Transactions
elbion NV Funding Round
3i Venture Capital and Burrill & Company participated in a $44.6 million Series A funding round for elbion NV. The funding round was recorded on 5/24/2005.
Transaction Overview
Company Name
Announced On
5/24/2005
Transaction Type
Venture Equity
Amount
$44,566,000
Round
Series A
Investors
Proceeds Purpose
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
Halvestraat 3
Leuven, 3000
Belgium
Leuven, 3000
Belgium
Phone
Website
Email Address
Overview
elbion discovers and develops new small molecule drugs. Inflammatory and central nervous system diseases with high unmet medical need and high commercial potential are at the center of elbion's project pipeline, which covers all stages from early hits to advanced clinical projects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernd Kastler
Browse more venture capital transactions:
Prev: 5/23/2005: Riskclick venture capital transaction
Next: 5/24/2005: RazorGator venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs